Kolorektalkreft
BM7PE En fase I/II studie med BM7PE immunotoxin gitt til pasienter som har tykk-endetarmskreft med spredning og som ikke tåler videre cellegift behandling, eller hvor etablert behandling ikke virker. Linker: OUS nettsider |
EVIDENT An open-label single arm interventional phase 2 study to investigate outcome of individualized treatment based on pharmacogenomic profiling and ex vivo drug sensitivity testing of patient-derived organoids in patients with metastatic colorectal cancer Linker: OUS nettsider |
MK4280A-007 A Phase 3 study of MK-4280A [co-formulated favezelimab (MK-4280) plus pembrolizumab (MK-3475)] Versus Standard of Care in Previously Treated Metastatic PD-L1 positive Colorectal Cancer Linker: ClinicalTrials.gov eller OUS nettsider |